Patent

MICRORNA FOR DIAGNOSIS OF PANCREATIC CANCER AND/OR PROGNOSIS OF PATIENTS WITH PANCREATIC CANCER BY BLOOD SAMPLES

Dimensions: US-20150011414-A1

Assignee

Original:

Current:

  • Herlev Hospital, Capital Region
  • Rigshospitalet, Capital Region
  • Heidelberg University
  • Danish Cancer Society

Abstract

The present invention relates to methods for improving the diagnosis and prognosis of patients with pancreatic carcinoma by making use of specific miRNA biomarkers associated with pancreatic carcinoma that may be identified based on a blood sample, in particular a whole blood, serum or plasma sample, from an individual.

Status

Publication year: 2015

 

Filing status: Application

Legal status: Abandoned

Research Categories

Main Subject Area

Fields of Research